Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling
Open accessThe DOI matches its Crossref record; 131 of the 133 references it cites were found in a registry or an index.
Abstract
Oxidative cellular damage caused by free radicals is known to contribute to the pathogenesis of various diseases such as cancer, diabetes, and neurodegenerative diseases, as well as to aging. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) and Kelch-like ECH-associated protein1 (Keap1) signaling pathways play an important role in preventing stresses including oxidative and inflammatory stresses. Nrf2 is a master regulator of cellular stress responses, induces the expression of antioxidant and detoxification enzymes, and protects against oxidative stress-induced cell damage. Glucagon-like peptide-1 (GLP-1) is an incretin hormone, which was originally found to increase insulin synthesis and secretion. It is now widely accepted that GLP-1 has multiple functions beyond glucose control in various tissues and organs including brain, kidney, and heart. GLP-1 and GLP-1 receptor agonists are known to be effective in many chronic diseases, including diabetes, via antioxidative mechanisms. In this review, we summarize the current knowledge regarding the role of GLP-1 in the protection against oxidative damage and the activation of the Nrf2 signaling pathway.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“dysfunction of endothelial cells, induced by hyperglycemia and driven by this systemic proinflammatory state, trigger cardiomyocyte dysfunction in HFpEF.”
From The cardioprotective effects of semaglutide exceed those of dietary weight loss in mice with HFpEF (2023) · cites this paper as [66]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The Nrf2 signaling pathway, a master regulator of cellular antioxidant defense mechanisms, is upregulated by GLP-1 receptor activation, according to preclinical research (49).”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Improvements in HF-related symptoms and physical function have been broadly recognized as key goals of care in patients with HFpEF by clinicians, professional societies and regulators. 45”
From Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials (2024) · cites this paper as [45]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Free radicals, metals and antioxidants in oxidative stress-induced cancer
Valko, M., Rhodes, C. J., Moncol, J., Izakovic, M., & Mazur, M. (2006) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2005.12.009 · Cited by 6,680
Oxidative stress, inflammation, and cancer: How are they linked?
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.09.006 · Cited by 5,441
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639 · cited 2×
“In addition to its actions on the pancreas, GLP-1 reduces glucose production in the liver and increases glucose uptake in adipose tissue and muscle [64,78,79].”
BackgroundCell Survival Responses to Environmental Stresses Via the Keap1-Nrf2-ARE Pathway
Kensler, T. W., Wakabayashi, N., & Biswal, S. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141046 · Cited by 3,630 · cited 2×
“Under basic conditions, Nrf2 is bound to the endogenous inhibitor Kelch-like ECH-associated protein1 (Keap1), which is anchored to actin in the cytoskeleton in the cytosol, and suppressed by Keap1-dependent ubiquitination-proteasomal degradation [8].”
BackgroundThe biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210 · cited 1×
“GLP-1 has many additional effects; it delays gastric emptying, inhibits food intake, improves insulin sensitivity, inhibits glucagon secretion, and stimulates insulin biosynthesis [18,53].”
BackgroundThe Nrf2 regulatory network provides an interface between redox and intermediary metabolism
Hayes, J. D., & Dinkova-Kostova, A. T. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.002 · Cited by 2,141 · cited 2×
“Nrf2–ARE binding regulates the expression of genes involved in cellular antioxidant and anti-inflammatory responses such as superoxide dismutase, catalase, glutathione peroxidases, thioredoxin, thioredoxin reductase, sulfiredoxin, NADPH:quinone oxidoreductase-1, heme oxygenase-1, glutathione reductase, glutaredoxin, g…”
BackgroundAntioxidants Maintain Cellular Redox Homeostasis by Elimination of Reactive Oxygen Species
He, L., He, T., Farrar, S., Ji, L., Liu, T., & Ma, X. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000485089 · Cited by 2,127
Cellular mechanisms and physiological consequences of redox-dependent signalling
Holmström, K. M., & Finkel, T. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3801 · Cited by 2,093
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Strategies of antioxidant defense
SIES, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb18025.x · Cited by 1,976
Jain, A., Lamark, T., Sjøttem, E., Bowitz Larsen, K., Atesoh Awuh, J., Øvervatn, A., McMahon, M., Hayes, J. D., & Johansen, T. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.118976 · Cited by 1,472 · cited 1×
“Moreover, Nrf2 promotes p62 (an autophagic adaptor protein sequestosome-1) expression, which is involved in mitophagy (maintains the mitochondrial integrity by removing damaged mitochondria) and helps maintain mitochondrial homeostasis [48,49].”
BackgroundRole of oxidative stress in cardiovascular diseases
Dhalla, N. S., Temsah, R. M., & Netticadan, T. (2000) · Journal of Hypertension · doi:10.1097/00004872-200018060-00002 · Cited by 1,467
Lipid peroxidation—DNA damage by malondialdehyde
Marnett, L. J. (1999) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(99)00010-x · Cited by 1,304
Lenzen, S., Drinkgern, J., & Tiedge, M. (1996) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(96)02051-5 · Cited by 1,165 · cited 2×
“i i l i l l l l t l ressi le els of a tioxi ant enzy es [92].”
BackgroundKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062 · cited 1×
“GLP-1R is widely expressed in various tissues including pancreatic islets, pancreatic ducts, kidney, lung, heart, skin, immune cells, and the central and peripheral nervous systems, hypothalamus, hippocampus, and the cortex [58].”
BackgroundHuang, H.-C., Nguyen, T., & Pickett, C. B. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206911200 · Cited by 1,034 · cited 1×
“Once the bonds are broken, Nrf2 becomes phosphorylated at Ser 40 and translocates to the nucleus of the cell [43].”
BackgroundOxidative Stress, Mitochondrial Dysfunction, and Aging
Cui, H., Kong, Y., & Zhang, H. (2012) · Journal of Signal Transduction · doi:10.1155/2012/646354 · Cited by 1,022 · cited 1×
“Many theories on aging have been proposed, and the free-radical theory suggests that cumulative damage to mitochondria and mitochondrial DNA caused by ROS is one of the important causes of aging and aging-related diseases [33].”
BackgroundThe emerging role of Nrf2 in mitochondrial function
Dinkova-Kostova, A. T., & Abramov, A. Y. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.04.036 · Cited by 983 · cited 2×
“Nrf2 activates the expression of genes promoting mitochondrial biogenesis and preservation, such as mitochondrial transcription factors, mitochondrial DNA-directed RNA polymerase, citrate synthase, NADH dehydrogenases, and Cox subunit 1 [47,48].”
BackgroundTissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 919 · cited 2×
“GLP-1 in the circulation is rapidly increased by nutrients such as carbohydrates, fats, proteins, and dietary fiber and is truncated and amidated into two active forms: GLP-1 (7–37) and GLP-1 (7–36) amide [14].”
BackgroundNiture, S. K., Khatri, R., & Jaiswal, A. K. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.008 · Cited by 868
Tebay, L. E., Robertson, H., Durant, S. T., Vitale, S. R., Penning, T. M., Dinkova-Kostova, A. T., & Hayes, J. D. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.06.021 · Cited by 837 · cited 2×
“Glucagon-like peptide-1 (GLP-1) is an incretin hormone that is produced mainly by the enteroendocrine L cells in the distal intestine in response to nutrient ingestion [5,14,15].”
BackgroundThe role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824 · cited 2×
“Many studies have reported on the preventive effects of GLP-1 and GLP-1R agonists on beta cells against various toxic stimuli including glucose, fatty acids, cytokines, and ROS [65].”
BackgroundOxidative damage to DNA in diabetes mellitus
Dandona, P., Thusu, K., Cook, S., Snyder, B., Makowski, J., Armstrong, D., & Nicotera, T. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90013-6 · Cited by 787
Farilla, L., Bulotta, A., Hirshberg, B., Li Calzi, S., Khoury, N., Noushmehr, H., Bertolotto, C., Di Mario, U., Harlan, D. M., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2003-0323 · Cited by 664 · cited 1×
“The anti-apoptotic effects of GLP-1 are mediated by increasing the anti-apoptotic proteins Bcl-2 and Bcl-xl and decreasing active caspase-3 [72] through cAMP and activation of PI3K, PKB, and EGFR–PI3K signaling pathways [73–75].”
BackgroundChemistry and Biochemistry of Oxidative Stress in Neurodegenerative Disease
Sayre, L., Smith, M., & Perry, G. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372922 · Cited by 607
The Influence of GLP-1 on Glucose-Stimulated Insulin Secretion
Kjems, L. L., Holst, J. J., Vølund, A., & Madsbad, S. (2003) · Diabetes · doi:10.2337/diabetes.52.2.380 · Cited by 582 · cited 1×
“Glucagon-like peptide-1 (GLP-1) is an incretin hormone that is produced mainly by the enteroendocrine L cells in the distal intestine in response to nutrient ingestion [5,14,15].”
BackgroundPiantadosi, C. A., Carraway, M. S., Babiker, A., & Suliman, H. B. (2008) · Circulation Research · doi:10.1161/01.res.0000338597.71702.ad · Cited by 578 · cited 1×
“Nrf2 activates the expression of genes promoting mitochondrial biogenesis and preservation, such as mitochondrial transcription factors, mitochondrial DNA-directed RNA polymerase, citrate synthase, NADH dehydrogenases, and Cox subunit 1 [47,48].”
BackgroundBasic Principles and Emerging Concepts in the Redox Control of Transcription Factors
Brigelius-Flohé, R., & Flohé, L. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3534 · Cited by 576 · cited 6×
“Nuclear factor (NF)-κB p65 and p-AKT/endothelial nitric oxide synthase (p-AKT/p-eNOS) pathways were involved in the neuroprotective effect [125].”
BackgroundInfluentialDing, X., Saxena, N. K., Lin, S., Gupta, N., & Anania, F. A. (2006) · Hepatology · doi:10.1002/hep.21006 · Cited by 557 · cited 1×
“Treatment with exendin-4 (10 or 20 μg/kg/d, 60 days) reversed hepatic steatosis in ob/ob mice by improving insulin sensitivity, and the level of thiobarbituric reactive substances as a marker of oxidative stress was significantly reduced in liver tissue of these mice [106].”
BackgroundOxidative stress and glycemic regulation
Ceriello, A. (2000) · Metabolism · doi:10.1016/s0026-0495(00)80082-7 · Cited by 550 · cited 2×
“Increased oxidative stress plays a major role in the development and progression of diabetes and its complications [90].”
BackgroundArakawa, M., Mita, T., Azuma, K., Ebato, C., Goto, H., Nomiyama, T., Fujitani, Y., Hirose, T., Kawamori, R., & Watada, H. (2010) · Diabetes · doi:10.2337/db09-1694 · Cited by 548
Nrf2 as a novel molecular target for chemoprevention
Lee, J.-S., & Surh, Y.-J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.09.042 · Cited by 516 · cited 1×
“Moreover, pharmacological activation of Nrf2 by various chemoprotective agents protects against oxidative damage [51].”
BackgroundOxidative stress, anti‐oxidant therapies and chronic kidney disease
SMALL, D. M., COOMBES, J. S., BENNETT, N., JOHNSON, D. W., & GOBE, G. C. (2012) · Nephrology · doi:10.1111/j.1440-1797.2012.01572.x · Cited by 514
Oxidative stress and protein aggregation during biological aging
Squier, T. C. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00139-5 · Cited by 508
Hunter, K., & Hölscher, C. (2012) · BMC Neuroscience · doi:10.1186/1471-2202-13-33 · Cited by 504 · cited 1×
“As GLP-1 agonists can cross the blood–brain barrier, the effect of GLP-1 treatment on cellular pathways involved in neuroinflammation, mitochondrial function, neuronal protection, and cellular proliferation within the central nervous system have been investigated [123].”
BackgroundFriling, R. S., Bensimon, A., Tichauer, Y., & Daniel, V (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.16.6258 · Cited by 475
Holmström, K. M., Baird, L., Zhang, Y., Hargreaves, I., Chalasani, A., Land, J. M., Stanyer, L., Yamamoto, M., Dinkova-Kostova, A. T., & Abramov, A. Y. (2013) · Biology Open · doi:10.1242/bio.20134853 · Cited by 448 · cited 2×
“and increases oxygen consumption and glucose uptake in skeletal muscle [95,96].”
BackgroundMechanism of Regulation of the Epac Family of cAMP-dependent RapGEFs
de Rooij, J., Rehmann, H., van Triest, M., Cool, R. H., Wittinghofer, A., & Bos, J. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001113200 · Cited by 398 · cited 1×
“GLP-1-induced insulin secretion is mainly regulated by cAMP–PKA and exchange proteins activated by cAMP (Epac)2 signaling pathways [59].”
BackgroundKukreja, R. C., & Hess, M. L. (1992) · Cardiovascular Research · doi:10.1093/cvr/26.7.641 · Cited by 396
Role of Oxidant Species in Aging
Stadtman, E. R. (2004) · Current Medicinal Chemistry · doi:10.2174/0929867043365341 · Cited by 368
Li, Y., & Jaiswal, A. K. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42151-5 · Cited by 353
Long-Acting Glucagon-Like Peptide 1 Receptor Agonists
Garber, A. J. (2011) · Diabetes Care · doi:10.2337/dc11-s231 · Cited by 350 · cited 1×
“control of blood glucose, GLP-1 is now widely used in the clinic for diabetic patients [19,20].”
BackgroundPerry, T., Lahiri, D. K., Sambamurti, K., Chen, D., Mattson, M. P., Egan, J. M., & Greig, N. H. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10611 · Cited by 347
Fujita, H., Morii, T., Fujishima, H., Sato, T., Shimizu, T., Hosoba, M., Tsukiyama, K., Narita, T., Takahashi, T., Drucker, D. J., et al. (2014) · Kidney International · doi:10.1038/ki.2013.427 · Cited by 336
The Keap1-Nrf2 System Prevents Onset of Diabetes Mellitus
Uruno, A., Furusawa, Y., Yagishita, Y., Fukutomi, T., Muramatsu, H., Negishi, T., Sugawara, A., Kensler, T. W., & Yamamoto, M. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00225-13 · Cited by 328 · cited 2×
“and increases oxygen consumption and glucose uptake in skeletal muscle [95,96].”
BackgroundLiu, Z., & Habener, J. F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m706105200 · Cited by 326 · cited 1×
“Transcription factor 7-like 2 and Wnt/β-catenin signaling pathways are also involved in GLP-1-induced insulin secretion and beta cell proliferation [70,71].”
BackgroundZhou, J., Wang, X., Pineyro, M. A., & Egan, J. M. (1999) · Diabetes · doi:10.2337/diabetes.48.12.2358 · Cited by 319 · cited 1×
“GLP-1 or exendin-4 treatment can convert rat or human pancreatic exocrine cells into glucagon-, insulin-, or pancreatic polypeptide-containing cells, and acinar pancreatic cells can differentiate into insulin-producing cells through PKC, MAPK signaling, and pancreatic and duodenal homeobox 1 (Pdx-1) regulation [76].”
BackgroundMolecular Basis of Electrophilic and Oxidative Defense: Promises and Perils of Nrf2
Ma, Q., & He, X. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.004333 · Cited by 317 · cited 1×
“Knockout of Nrf2 in mice increased their susceptibility to various chemical toxicity and disease conditions associated with oxidative pathologies such as type 2 diabetes, cancer, cardiovascular disease, and neurodegenerative disease and also aging [8,50].”
BackgroundAnti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells
Lee, Y.-S., & Jun, H.-S. (2014) · Metabolism · doi:10.1016/j.metabol.2013.09.010 · Cited by 315
Self-citationHui, H., Nourparvar, A., Zhao, X., & Perfetti, R. (2003) · Endocrinology · doi:10.1210/en.2002-220897 · Cited by 307
The Nrf2/Keap1/ARE Pathway and Oxidative Stress as a Therapeutic Target in Type II Diabetes Mellitus
David, J. A., Rifkin, W. J., Rabbani, P. S., & Ceradini, D. J. (2017) · Journal of Diabetes Research · doi:10.1155/2017/4826724 · Cited by 301
PGAM5 tethers a ternary complex containing Keap1 and Nrf2 to mitochondria
Lo, S.-C., & Hannink, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.02.014 · Cited by 300 · cited 1×
“In addition to their location in the cytoskeleton, Nrf2 and Keap1 have also been detected at the outer mitochondrial membrane, binding to mitochondrial phosphatase phosphoglycerate mutase (PGAM) family member 5 [46] and affecting mitochondrial function.”
BackgroundPerry, T., Lahiri, D. K., Chen, D., Zhou, J., Shaw, K. T. Y., Egan, J. M., & Greig, N. H. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.958 · Cited by 300 · cited 1×
“Activation of GLP-1R signaling enhances neurogenesis, reduces apoptosis, and protects neuronal function [80,81], suggesting that GLP-1 could be beneficial for the treatment of neurodegenerative disorders [82].”
BackgroundThe Roles of ROS in Cancer Heterogeneity and Therapy
de Sá Junior, P. L., Câmara, D. A. D., Porcacchia, A. S., Fonseca, P. M. M., Jorge, S. D., Araldi, R. P., & Ferreira, A. K. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2467940 · Cited by 287
Oeseburg, H., de Boer, R. A., Buikema, H., van der Harst, P., van Gilst, W. H., & Silljé, H. H. W. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.110.206425 · Cited by 267
Glucagon gene expression in vertebrate brain.
Drucker, D. J., & Asa, S. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68261-4 · Cited by 264
Bajaj, S., & Khan, A. (2012) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.104057 · Cited by 259 · cited 1×
“Increased production of free radicals and ROS and impaired antioxidant defense accompany both type 1 and type 2 diabetes [91].”
BackgroundButeau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., & Prentki, M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2237 · Cited by 252
Oxidative stress and frailty: A systematic review and synthesis of the best evidence
Soysal, P., Isik, A. T., Carvalho, A. F., Fernandes, B. S., Solmi, M., Schofield, P., Veronese, N., & Stubbs, B. (2017) · Maturitas · doi:10.1016/j.maturitas.2017.01.006 · Cited by 252
Hendarto, H., Inoguchi, T., Maeda, Y., Ikeda, N., Zheng, J., Takei, R., Yokomizo, H., Hirata, E., Sonoda, N., & Takayanagi, R. (2012) · Metabolism · doi:10.1016/j.metabol.2012.03.002 · Cited by 232 · cited 2×
“The author demonstrated that PKA-mediated inhibition of renal NADPH oxidase was involved in protecting against diabetic nephropathy in STZ-induced diabetic rats [121].”
BackgroundGlucagon-like peptide-1 inhibits LPS-induced IL-1β production in cultured rat astrocytes
Iwai, T., Ito, S., Tanimitsu, K., Udagawa, S., & Oka, J.-I. (2006) · Neuroscience Research · doi:10.1016/j.neures.2006.04.008 · Cited by 207
Wang, Q., Li, L., Xu, E., Wong, V., Rhodes, C., & Brubaker, P. L. (2004) · Diabetologia · doi:10.1007/s00125-004-1327-5 · Cited by 206 · cited 1×
“PI3K, PKC, PKB, c-Src, and MAPK signaling pathways mediate GLP-1-induced pancreatic beta cell proliferation [68,69].”
BackgroundCeriello, A., Novials, A., Ortega, E., Canivell, S., La Sala, L., Pujadas, G., Esposito, K., Giugliano, D., & Genovese, S. (2013) · Diabetes Care · doi:10.2337/dc12-2469 · Cited by 204 · cited 1×
“4 pmol/kg/min) for 2 h reduced 8-iso-prostaglandin F2α (8-iso-PGF2α) and nitrotyrosine (oxidative stress markers) in plasma during a hypoglycemia or hyperglycemia clamp in both type 1 and type 2 diabetic patients [108,109].”
BackgroundTeramoto, S., Miyamoto, N., Yatomi, K., Tanaka, Y., Oishi, H., Arai, H., Hattori, N., & Urabe, T. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.51 · Cited by 201 · cited 1×
“After exendin-4 (10 μg/kg) treatment, the intracellular cAMP level was increased and neuroprotective effects were observed in these mice [124].”
BackgroundPotential Role of Glucagon-Like Peptide-1 (GLP-1) in Neuroprotection
Hölscher, C. (2012) · CNS Drugs · doi:10.2165/11635890-000000000-00000 · Cited by 191 · cited 1×
“Activation of GLP-1R signaling enhances neurogenesis, reduces apoptosis, and protects neuronal function [80,81], suggesting that GLP-1 could be beneficial for the treatment of neurodegenerative disorders [82].”
BackgroundLiu, H., Dear, A. E., Knudsen, L. B., & Simpson, R. W. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0468 · Cited by 187
Zhu, H., Zhang, Y., Shi, Z., Lu, D., Li, T., Ding, Y., Ruan, Y., & Xu, A. (2016) · Scientific Reports · doi:10.1038/srep26859 · Cited by 183 · cited 2×
“demonstrated that liraglutide (500 nmol/L) inhibited oxygen/glucose deprivation apoptosis by reducing ROS in primary neurons and increasing the phosphorylation of AKT and ERK while decreasing phosphorylation of p-38 and c-Jun N-terminal kinase [127].”
BackgroundWang, D., Luo, P., Wang, Y., Li, W., Wang, C., Sun, D., Zhang, R., Su, T., Ma, X., Zeng, C., et al. (2013) · Diabetes · doi:10.2337/db12-1025 · Cited by 179 · cited 1×
“These effects were inhibited after treatment with GLP-1 (10 nmol/L); an increased cAMP/PKA and decreased Rho expression were also demonstrated in this study [117].”
BackgroundTranscription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic β-cell mass
Buteau, J., Spatz, M. L., & Accili, D. (2006) · Diabetes · doi:10.2337/db05-0825 · Cited by 178
Endoplasmic reticulum stress and Nrf2 signaling in cardiovascular diseases
Cominacini, L., Mozzini, C., Garbin, U., Pasini, A., Stranieri, C., Solani, E., Vallerio, P., Tinelli, I. A., & Fratta Pasini, A. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.027 · Cited by 175
Glucagon-Like Peptide-1: Glucose Homeostasis and Beyond
Cho, Y. M., Fujita, Y., & Kieffer, T. J. (2014) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021113-170315 · Cited by 174 · cited 1×
“GLP-1 has many additional effects; it delays gastric emptying, inhibits food intake, improves insulin sensitivity, inhibits glucagon secretion, and stimulates insulin biosynthesis [18,53].”
BackgroundIshibashi, Y., Matsui, T., Takeuchi, M., & Yamagishi, S.-I. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.075 · Cited by 173 · cited 1×
“This effect was mediated through the GLP1R-cAMP axis, resulting in a lower expression level of the receptors for advanced glycation end products and ROS generation [118].”
BackgroundRole of Endogenous Glucagon-Like Peptide-1 in Islet Regeneration After Partial Pancreatectomy
De León, D. D., Deng, S., Madani, R., Ahima, R. S., Drucker, D. J., & Stoffers, D. A. (2003) · Diabetes · doi:10.2337/diabetes.52.2.365 · Cited by 172 · cited 1×
“The increase in the beta cell mass in 70% pancreatectomized mice was significantly lower in GLP-1R-deficient mice compared with wild-type mice, indicating an important role of GLP-1 in beta cell regeneration [67].”
BackgroundGlucagon-like Peptide-1 and the Central/Peripheral Nervous System: Crosstalk in Diabetes
Muscogiuri, G., DeFronzo, R. A., Gastaldelli, A., & Holst, J. J. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.10.001 · Cited by 171 · cited 1×
“The pretreatment blocked the elevated levels of lipid peroxidation markers and decreased the activity of antioxidant molecules such as glutathione and superoxide dismutase seen in brain tissue of ischemic controls [126].”
BackgroundOxidative stress and genetic and epidemiologic determinants of oxidant injury in childhood asthma
Ercan, H., Birben, E., Dizdar, E. A., Keskin, O., Karaaslan, C., Soyer, O. U., Dut, R., Sackesen, C., Besler, T., & Kalayci, O. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.012 · Cited by 170
Nrf2 and Cardiovascular Defense
Howden, R. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/104308 · Cited by 162
Batchuluun, B., Inoguchi, T., Sonoda, N., Sasaki, S., Inoue, T., Fujimura, Y., Miura, D., & Takayanagi, R. (2014) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.10.025 · Cited by 161 · cited 1×
“A combination of liraglutide (30 nmol/L) and metformin inhibited these pathways and reduced oxidative stress [119].”
BackgroundShimoda, M., Kanda, Y., Hamamoto, S., Tawaramoto, K., Hashiramoto, M., Matsuki, M., & Kaku, K. (2011) · Diabetologia · doi:10.1007/s00125-011-2069-9 · Cited by 161 · cited 2×
“Moreover, exendin-4 ameliorated myocardial oxidative stress via suppression of the ROS generating enzyme, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4, with concomitant elevation of antioxidant enzymes (superoxide dismutase-1 and glutathione peroxidase) [105].”
BackgroundScopsi, L. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.1.294 · Cited by 141 · cited 4×
“Processing of proglucagon by prohormone convertase 1/3 in the gut and brain produces GLP-1, GLP-2, oxyntomodulin, glicentin, and intervening peptide-2 [55], and GLP-1 is the major peptide generated from proglucagon in the intestine.”
BackgroundInfluentialCeriello, A., Esposito, K., Testa, R., Bonfigli, A. R., Marra, M., & Giugliano, D. (2011) · Diabetes Care · doi:10.2337/dc10-1949 · Cited by 134 · cited 1×
“4 pmol/kg/min) for 2 h reduced 8-iso-prostaglandin F2α (8-iso-PGF2α) and nitrotyrosine (oxidative stress markers) in plasma during a hypoglycemia or hyperglycemia clamp in both type 1 and type 2 diabetic patients [108,109].”
BackgroundTremblay, A. J., Lamarche, B., Deacon, C. F., Weisnagel, S. J., & Couture, P. (2014) · Metabolism · doi:10.1016/j.metabol.2014.06.004 · Cited by 132 · cited 1×
“control of blood glucose, GLP-1 is now widely used in the clinic for diabetic patients [19,20].”
BackgroundBunck, M. C., Cornér, A., Eliasson, B., Heine, R. J., Shaginian, R. M., Wu, Y., Yan, P., Smith, U., Yki-Järvinen, H., Diamant, M., et al. (2010) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2010.04.024 · Cited by 132 · cited 1×
“One year of treatment with exenatide (10 μg/d) reduced postprandial glycemia and lipidemia in type 2 diabetic patients, and these effects were related to decreased malondialdehyde (a lipid peroxidation marker) and oxidized low-density lipoproteins [111].”
BackgroundSkoglund, G., Hussain, M. A., & Holz, G. G. (2000) · Diabetes · doi:10.2337/diabetes.49.7.1156 · Cited by 127
Sitagliptin Prevents Inflammation and Apoptotic Cell Death in the Kidney of Type 2 Diabetic Animals
Marques, C., Mega, C., Gonçalves, A., Rodrigues-Santos, P., Teixeira-Lemos, E., Teixeira, F., Fontes-Ribeiro, C., Reis, F., & Fernandes, R. (2014) · Mediators of Inflammation · doi:10.1155/2014/538737 · Cited by 126
Parthsarathy, V., & Hölscher, C. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.12.012 · Cited by 119
4-Hydroxynonenal formation during ischemia and reperfusion of rat small intestine
Siems, W. G., Grune, T., & Esterbauer, H. (1995) · Life Sciences · doi:10.1016/0024-3205(95)02006-5 · Cited by 117
Lawrence, M. C., Bhatt, H. S., & Easom, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.3.691 · Cited by 115
Oxidative stress and its determinants in the airways of children with asthma
Dut, R., Dizdar, E. A., Birben, E., Saçkesen, C., Soyer, O. U., Besler, H. T., & Kalaycı, Ö. (2008) · Allergy · doi:10.1111/j.1398-9995.2008.01766.x · Cited by 114
LARSSON, H., HOLST, J. J., & AHRÉN, B. (1997) · Acta Physiologica Scandinavica · doi:10.1046/j.1365-201x.1997.00161.x · Cited by 114 · cited 1×
“In addition to its actions on the pancreas, GLP-1 reduces glucose production in the liver and increases glucose uptake in adipose tissue and muscle [64,78,79].”
BackgroundFunctional pancreatic beta-cell mass: Involvement in type 2 diabetes and therapeutic intervention
Karaca, M., Magnan, C., & Kargar, C. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.09.007 · Cited by 114
Rizzo, M., Abate, N., Chandalia, M., Rizvi, A. A., Giglio, R. V., Nikolic, D., Marino Gammazza, A., Barbagallo, I., Isenovic, E. R., Banach, M., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-2291 · Cited by 113 · cited 1×
“2 mg/d) to type 2 diabetic patients reduced serum lipid hydroperoxides and heme oxygenase 1, as well as significantly reduced glycated hemoglobin [110].”
BackgroundWang, X.-C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i40.14821 · Cited by 109
Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice
da Silva Xavier, G., Mondragon, A., Sun, G., Chen, L., McGinty, J. A., French, P. M., & Rutter, G. A. (2012) · Diabetologia · doi:10.1007/s00125-012-2600-7 · Cited by 109 · cited 1×
“Transcription factor 7-like 2 and Wnt/β-catenin signaling pathways are also involved in GLP-1-induced insulin secretion and beta cell proliferation [70,71].”
BackgroundLi, Y., Bader, M., Tamargo, I., Rubovitch, V., Tweedie, D., Pick, C. G., & Greig, N. H. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13169 · Cited by 103 · cited 1×
“Moreover, pretreatment with liraglutide rescued cells from H2O2- or glutamate-induced cell death and led to behavioral improvements in a mouse model of traumatic brain injury [128].”
BackgroundTomás, E., Stanojevic, V., & Habener, J. F. (2011) · Regulatory Peptides · doi:10.1016/j.regpep.2011.01.003 · Cited by 103 · cited 1×
“GLP-1 (28-36) amide (100 nmol/L) also inhibited ROS formation and restored cellular ATP levels, therefore suppressing glucose production in hepatocytes isolated from high fat diet-induced diabetic mice [102].”
BackgroundZhou, J., Pineyro, M. A., Wang, X., Doyle, M. E., & Egan, J. M. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10143 · Cited by 95 · cited 2×
“GLP-1 or exendin-4 treatment can convert rat or human pancreatic exocrine cells into glucagon-, insulin-, or pancreatic polypeptide-containing cells, and acinar pancreatic cells can differentiate into insulin-producing cells through PKC, MAPK signaling, and pancreatic and duodenal homeobox 1 (Pdx-1) regulation [76].”
BackgroundMukai, E., Fujimoto, S., Sato, H., Oneyama, C., Kominato, R., Sato, Y., Sasaki, M., Nishi, Y., Okada, M., & Inagaki, N. (2011) · Diabetes · doi:10.2337/db10-0021 · Cited by 92 · cited 1×
“When treated with an Epac-specific cAMP analog (9CPT-2Me-cAMP), Src phosphorylation and ROS production were decreased, suggesting that Epac-mediated Src inactivation is involved in the antioxidant effect of exendin-4, but not PKA or MAPK/ERK signaling pathways [100].”
Backgroundバトチュルーン, バ. (2014) · Institutional Repositories DataBase (IRDB) · doi:10.15017/1470539 · Cited by 92
Wang, H., Iezzi, M., Theander, S. S., Antinozzi, P. A., Gauthier, B. R., Halban, P. A., & Wollheim, C. B. (2005) · Diabetologia · doi:10.1007/s00125-005-1692-8 · Cited by 89
Wang, Y., Egan, J., Raygada, M. J., Nadiv, O., Roth, J., & Montrose‐Rafizadeh, C. (1995) · Endocrinology · doi:10.1210/en.136.11.4910 · Cited by 88 · cited 1×
“The increase of proinsulin gene transcription by GLP-1 is mediated by upregulation of the expression of pancreas duodenum homeobox 1, a beta cell transcription factor [60].”
BackgroundGLP-1 Inhibits High-Glucose-Induced Oxidative Injury of Vascular Endothelial Cells
Li, Q., Lin, Y., Wang, S., Zhang, L., & Guo, L. (2017) · Scientific Reports · doi:10.1038/s41598-017-06712-z · Cited by 87 · cited 1×
“STZ- and high fat diet-induced diabetic rats showed a significant increase in oxidative damage of the aorta detected by NADPH oxidase 4 and VCAM-1 expression, and these increases were reversed by exenatide (10 μg/kg) treatment [120].”
BackgroundEnhanced expression of PDX-1 and Ngn3 by exendin-4 during β cell regeneration in STZ-treated mice
Kodama, S., Toyonaga, T., Kondo, T., Matsumoto, K., Tsuruzoe, K., Kawashima, J., Goto, H., Kume, K., Kume, S., Sakakida, M., et al. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.120 · Cited by 86
Silva‐Palacios, A., Königsberg, M., & Zazueta, C. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.12.005 · Cited by 86
Cardioprotective effects of exenatide against oxidative stress-induced injury
CHANG, G., ZHANG, D., YU, H., ZHANG, P., WANG, Y., ZHENG, A., & QIN, S. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1475 · Cited by 85 · cited 1×
“Increased apoptosis, mitochondrial dysfunction, and ROS production in cardiomyocytes (H9C2) by H2O2 and hypoxia/reoxygenation were ameliorated by exenatide (1 and 200 nmol/L), and the effect was associated with activation of the PI3K/AKT signaling pathway [115,116].”
BackgroundThe Antioxidant Response Element and Oxidative Stress Modifiers in Airway Diseases
Reddy, S. (2008) · Current Molecular Medicine · doi:10.2174/156652408785160925 · Cited by 83 · cited 1×
“c-Jun acts mainly as a transcriptional activator, while the small Mafs inactivate gene transcription after Nrf2 binding [44].”
BackgroundBlandino-Rosano, M., Perez-Arana, G., Mellado-Gil, J. M., Segundo, C., & Aguilar-Diosdado, M. (2008) · Journal of Molecular Endocrinology · doi:10.1677/jme-07-0154 · Cited by 82
Green, C. J., Henriksen, T. I., Pedersen, B. K., & Solomon, T. P. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044284 · Cited by 80 · cited 1×
“In addition to its actions on the pancreas, GLP-1 reduces glucose production in the liver and increases glucose uptake in adipose tissue and muscle [64,78,79].”
BackgroundCivantos, E., Bosch, E., Bustillo, E. R., Zhenyukh, O., Egido, J., Lorenzo, Ó., & Mas, S. (2017) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s132537 · Cited by 75 · cited 1×
“Treatment with sitagliptin (a DPP-4 inhibitor, 10 mg/d for 20 weeks) decreased the expression of antioxidant response genes (peroxiredoxin and glutathione S-transferase) in the kidney from diabetic Goto-Kakizaki rats, and downregulation of miR-200a was involved in the protective effect [122].”
BackgroundEpac is Required for GLP-1R-Mediated Inhibition of Oxidative Stress and Apoptosis in Cardiomyocytes
Mangmool, S., Hemplueksa, P., Parichatikanond, W., & Chattipakorn, N. (2015) · Molecular Endocrinology · doi:10.1210/me.2014-1346 · Cited by 69 · cited 1×
“Treatment with exendin-4 (20 nmol/L) in neonatal rat cardiomyocytes attenuated H2O2-induced ROS production and increased the synthesis of antioxidant enzymes such as catalase, glutathione peroxidase-1, and manganese superoxide dismutase, and the effect was dependent on GLP-1R-mediated Epac pathways [114].”
BackgroundFernández‐Millán, E., Martín, M. Á., Goya, L., Lizárraga-Mollinedo, E., Escrivá, F., Ramos, S., & Álvarez, C. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.002 · Cited by 68 · cited 1×
“Enhanced cellular levels of glutathione and the activity of its related enzymes—glutathione-peroxidase and -reductase—was observed in these GLP-1-treated cells, and the cAMP–mediated PKA/extracellular signal-regulated kinase (ERK) pathway was involved in antioxidant enzyme regulation [98].”
BackgroundYang, B., Fu, J., Zheng, H., Xue, P., Yarborough, K., Woods, C. G., Hou, Y., Zhang, Q., Andersen, M. E., & Pi, J. (2012) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2012.09.012 · Cited by 67 · cited 2×
“Nrf2 knockdown in a mouse insulinoma cell line (MIN6) or pancreatic islets isolated from Nrf2knockout mice are vulnerable to arsenic-induced cell damage [93], and pharmacological activation of Nrf2 improves islet yield and islet function after transplantation [94], indicating that Nrf2 plays a significant role in the…”
BackgroundThe Bad, the Good, and the Ugly about Oxidative Stress
Jimenez-Del-Rio, M., & Velez-Pardo, C. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/163913 · Cited by 64
Zhao, L., Li, A. Q., Zhou, T. F., Zhang, M. Q., & Qin, X. M. (2014) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00151.2014 · Cited by 61
Chang, G., Zhang, D., Liu, J., Zhang, P., Ye, L., Lu, K., Duan, Q., Zheng, A., & Qin, S. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370214522177 · Cited by 59 · cited 1×
“Increased apoptosis, mitochondrial dysfunction, and ROS production in cardiomyocytes (H9C2) by H2O2 and hypoxia/reoxygenation were ameliorated by exenatide (1 and 200 nmol/L), and the effect was associated with activation of the PI3K/AKT signaling pathway [115,116].”
BackgroundGLP-1 Agonists Exenatide and Liraglutide: A Review About Their Safety and Efficacy
Derosa, G., & Maffioli, P. (2012) · Current Clinical Pharmacology · doi:10.2174/157488412800958686 · Cited by 58 · cited 1×
“Studies show that GLP-1 increases beta cell proliferation and neogenesis and inhibits beta cell apoptosis, contributing to the regulation of the beta cell mass [65,66].”
BackgroundKim, M.-H., Kim, E.-H., Jung, H. S., Yang, D., Park, E.-Y., & Jun, H. (2016) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2016.12.005 · Cited by 56 · cited 1×
“The author demonstrated that PKCδ-mediated Nrf2 activation contributed to the increase in antioxidant gene expression and consequently improved beta cell function in the presence of oxidative stress [101] (Figure 2).”
BackgroundSelf-citationRole of the Nrf2 signaling system in health and disease
Hybertson, B. M., & Gao, B. (2014) · Clinical Genetics · doi:10.1111/cge.12474 · Cited by 54
Romaní-Pérez, M., Outeiriño-Iglesias, V., Gil-Lozano, M., González-Matías, L. C., Mallo, F., & Vigo, E. (2013) · Endocrinology · doi:10.1210/en.2012-1786 · Cited by 51
Mechanism of the beneficial and protective effects of exenatide in diabetic rats
Lotfy, M. A., Singh, J., Rashed, H., Tariq, S., Zilahi, E., & Adeghate, E. A. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0426 · Cited by 51 · cited 1×
“Moreover, an increased number of catalase- and glutathione reductase-positive cells in pancreas was observed [104].”
BackgroundTews, D., Lehr, S., Hartwig, S., Osmers, A., Paßlack, W., & Eckel, J. (2009) · Hormone and Metabolic Research · doi:10.1055/s-0028-1105911 · Cited by 50 · cited 1×
“Incubation of INS-1 cells with cytokines increased apoptosis via high ROS generation, and this was completely prevented after preincubation with the GLP-1R agonist, exendin-4 [99].”
BackgroundLi, J., Zheng, J., Wang, S., Lau, H. K., Fathi, A., & Wang, Q. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00015 · Cited by 47
Chien, C.-T., Jou, M.-J., Cheng, T.-Y., Yang, C.-H., Yu, T.-Y., & Li, P.-C. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.126 · Cited by 46 · cited 1×
“Nuclear factor (NF)-κB p65 and p-AKT/endothelial nitric oxide synthase (p-AKT/p-eNOS) pathways were involved in the neuroprotective effect [125].”
BackgroundGLP-1 receptor independent pathways: emerging beneficial effects of GLP-1 breakdown products
Guglielmi, V., & Sbraccia, P. (2016) · Eating and Weight Disorders - Studies on Anorexia Bulimia and Obesity · doi:10.1007/s40519-016-0352-y · Cited by 42 · cited 1×
“Emerging evidence indicates that GLP-1 metabolites also have many beneficial effects, such as inhibition of hepatic glucose production, cardio- and neuroprotective effects, reduction of oxidative stress in the vasculature, and both antiapoptotic and proliferative effects in pancreatic beta cells [57].”
BackgroundPuddu, A., Mach, F., Nencioni, A., Viviani, G. L., & Montecucco, F. (2013) · Mediators of Inflammation · doi:10.1155/2013/591056 · Cited by 35
Ravassa, S., Beaumont, J., Huerta, A., Barba, J., Coma-Canella, I., González, A., López, B., & Díez, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.01.002 · Cited by 34 · cited 2×
“Moreover, GLP-1 restored mitochondrial membrane permeability and cytochrome c oxidase activity, consequently inhibiting oxidative damage in mitochondria [113].”
BackgroundPharmacological Activation of Nrf2 Pathway Improves Pancreatic Islet Isolation and Transplantation
Li, S., Vaziri, N. D., Masuda, Y., Hajighasemi‐Ossareh, M., Robles, L. Y., Le, A., Vo, K. M., Chan, J. Y., Foster, C. E., Stamos, M. J., et al. (2015) · Cell Transplantation · doi:10.3727/096368915x686210 · Cited by 29 · cited 2×
“Nrf2 knockdown in a mouse insulinoma cell line (MIN6) or pancreatic islets isolated from Nrf2knockout mice are vulnerable to arsenic-induced cell damage [93], and pharmacological activation of Nrf2 improves islet yield and islet function after transplantation [94], indicating that Nrf2 plays a significant role in the…”
BackgroundPATEL, V. G., Joharapurkar, A. A., Dhanesha, N., Kshirsagar, S. G., Detroja, J., Patel, K. N., Gandhi, T. R., Patel, K. V., Bahekar, R. H., & Jain, M. R. (2013) · Pharmacological Reports · doi:10.1016/s1734-1140(13)71074-0 · Cited by 28 · cited 1×
“A combination of omeprazole (30 mg/kg/d) and exendin-4 (8 μg/kg/d) treatment for four weeks in STZ-induced diabetic mice improved blood glucose levels compared with either exendin-4 or omeprazole alone, which was correlated with reduced liver lipid peroxidation and increased Nrf-2 expression [107].”
BackgroundOkada, K., Kotani, K., Yagyu, H., Ando, A., Osuga, J.-I., & Ishibashi, S. (2014) · Endocrine · doi:10.1007/s12020-014-0246-6 · Cited by 28 · cited 1×
“74 mg/d) did not affect serum levels of malondialdehyde [112].”
BackgroundEffects of incretin-based therapies on renal function
Tsimihodimos, V., & Elisaf, M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.049 · Cited by 22 · cited 1×
“GLP-1R activation affects renal function [83] and has pleiotropic cardioprotective effects [84].”
BackgroundGlucagon-Like Peptide-1 (GLP-1) Receptor Agonists in Cardiac Disorders
Wroge, J., & Williams, N. T. (2016) · Annals of Pharmacotherapy · doi:10.1177/1060028016663218 · Cited by 17 · cited 1×
“GLP-1R activation affects renal function [83] and has pleiotropic cardioprotective effects [84].”
BackgroundWu, Y., Huang, J., Liu, J., Jin, M., Gu, M., Hong, Y., & Wu, Z. (2011) · Journal of Peptide Science · doi:10.1002/psc.1352 · Cited by 11 · cited 1×
“Recombinant human GLP-1 (24 nmol/kg/d) reduced hyperglycemia in streptozotocin (STZ)-induced diabetic mice, and superoxide dismutase and glutathione peroxidase activities were enhanced in the pancreas [103].”
Background
Cited by
Burgos-Morón, E., Abad-Jiménez, Z., Martínez de Marañón, A., Iannantuoni, F., Escribano-López, I., López-Domènech, S., Salom, C., Jover, A., Mora, V., Roldan, I., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8091385 · Cited by 581
Butler, J., Shah, S. J., Petrie, M. C., Borlaug, B. A., Abildstrøm, S. Z., Davies, M. J., Hovingh, G. K., Kitzman, D. W., Møller, D. V., Verma, S., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00469-0 · Cited by 386
Flavonoids: A treasure house of prospective pharmacological potentials
Hasnat, H., Shompa, S. A., Islam, M. M., Alam, S., Richi, F. T., Emon, N. U., Ashrafi, S., Ahmed, N. U., Chowdhury, M. N. R., Fatema, N., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27533 · Cited by 263
“However, flavonoids block MAPK activation [129,210] as well as the Nrf-2 signaling pathway [116,212] (Figs.”
BackgroundZhao, T., Wu, W., Sui, L., Huang, Q., Nan, Y., Liu, J., & Ai, K. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.06.006 · Cited by 267
“Ginsenoside Rg3 (Rg3), the active constituent in ginseng, has been shown to prevent myocardial ischemia reperfusion injury via enhancing the SOD activity [24].”
BackgroundInfluentialRekatsina, M., Paladini, A., Piroli, A., Zis, P., Pergolizzi, J. V., & Varrassi, G. (2020) · Advances in Therapy · doi:10.1007/s12325-019-01148-5 · Cited by 252
Metadata
- Authors
- Oh, Y., & Jun, H.-S.
- Affiliations
- Eulji University (KR)
- Gachon University (KR)
- Corresponding author
- Jun, Hee-Sook
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-12-22
- Volume
- 19
- Issue
- 1
- Pages
- 26
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5795977
- OpenAlex
- W2779001901
- Semantic Scholar
- 8fd8d98ecad3afa2039a39b8a6478a9494f9a746
- Cited by
- 217
- References
- 133
- Citations by year
- 2026: 24 · 2025: 50 · 2024: 41 · 2023: 19 · 2022: 21 · 2021: 31 · 2020: 12 · 2019: 9 · 2018: 9 · 2017: 1
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation
- Korea Health Industry Development Institute (HI15C0987)
- National Research Foundation of Korea (NRF-2015R1D1A1A01058888)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics, phytochemicals, and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucagon-like peptide-1, Nrf2 signaling, Keap1, oxidative stress, antioxidant defense, incretins, GLP-1 receptor agonists, free radicals, cellular stress response, diabetes mellitus
- MeSH terms
- Animals, Diabetes Mellitus, Humans, Nervous System Diseases, Signal Transduction, Reactive Oxygen Species, Oxidative Stress, NF-E2-Related Factor 2, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.